Presumably, once they actually get results that can be published they'll do so. If they don't, they'll have a lot of trouble gaining credibility in the biosciences.

That said, in science bad management is kind of the norm. Many big labs in academia are horribly run yet consistently publish huge results. In industry the counterbalance is the ability to easily move on to a different employer, which seems to be what's happening. If true, the bad management should correct itself. One hopes.

Full disclosure: I work at a company that could be seen as in the same area as Verily.